NCT05982756 2023-08-09
Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML
Zhongnan Hospital
Phase 1 Unknown
Clinical Trials
5 trialsNCT05137860 2022-01-18
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD
Hospital General de Mexico
Phase 4 Unknown
NCT01950611 2013-09-25
PIAPL
Christian Medical College, Vellore, India
Phase 2 Unknown
NCT01328236 2011-09-22
Bortezomib
Clinical Service, China
Phase 2 Unknown
NCT00510939 2009-08-14
HEMOS AML 0106
University of Bologna
Phase 2 Unknown